BRONCHIAL MICROBIOME IN PATIENTS WITH LUNG CANCER

J. Vengoechea Aragoncillo (Zaragoza, Spain), A. Figueredo (Zaragoza, Spain), M. Cobo (Madrid, Spain), L. Torralba (Zaragoza, Spain), J. Errasti (Zaragoza, Spain), E. Minchole (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)

Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Session: Lung cancer: new aspects in diagnosis and management
Session type: Oral Presentation
Number: 3303
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vengoechea Aragoncillo (Zaragoza, Spain), A. Figueredo (Zaragoza, Spain), M. Cobo (Madrid, Spain), L. Torralba (Zaragoza, Spain), J. Errasti (Zaragoza, Spain), E. Minchole (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain). BRONCHIAL MICROBIOME IN PATIENTS WITH LUNG CANCER. 3303

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IMMUNOLOGICAL EVENTS AND SURVIVAL IN LUNG CANCER PATIENTS WITH COPD
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018




CORRELATION BETWEEN LUNG AND JOINT INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: CROSS SECTIONAL STUDY
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

EXHALED NITRIC OXIDE MEASUREMENTS IN PATIENTS WITH ACUTE-ONSET INTERSTITIAL LUNG DISEASE
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



PROTEOMIC ANALYSIS OF BLOOD SERUM OF CHILDREN WITH BRONCHIAL ASTHMA
Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors
Year: 2019


QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020

IMPACT OF TELEMONITORING ON PATIENTS WITH ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019


ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021


FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018


DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS.
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020

PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


PECULIARITIES OF CYTOKINE DYNAMICS IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018